Apella Capital’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.84M Buy
5,575
+1,632
+41% +$510K 0.02% 295
2026
Q2
$1.29M Buy
3,943
+593
+18% +$180K 0.02% 331
2026
Q1
$896K Buy
3,350
+152
+5% +$34K 0.01% 380
2025
Q4
$547K Buy
3,198
+21
+0.7% +$3.27K 0.01% 342
2025
Q3
$452K Buy
3,177
+51
+2% +$5.4K 0.01% 339
2025
Q2
$307K Sell
3,126
-155
-5% -$12.3K 0.01% 349
2025
Q1
$233K Buy
3,281
+27
+0.8% +$2.13K 0.01% 352
2024
Q4
$235K Sell
3,254
-29,576
-90% -$2.24M 0.01% 314
2024
Q3
$262K Buy
32,830
+29,670
+939% +$2.58M 0.01% 283
2024
Q2
$352K Buy
3,160
+10
+0.3% +$959 0.02% 235
2024
Q1
$307K Hold
3,150
– – 0.02% 243
2023
Q4
$230K Buy
+3,150
New +$215K 0.01% 265

Other funds holding LRCX

Apella Capital's LRCX Position: Q3 2026 in Review

Apella Capital increased its Lam Research (LRCX) stake by 41% in Q3 2026, buying an estimated $510K and bringing the position to 5,575 shares worth $1.84M. The position accounts for 0.02% of the portfolio, ranked #295.

Apella Capital first reported a position in LRCX in Q4 2023 and has held it in 12 quarters since. 130 funds tracked by Wall St. Rank hold LRCX as of Q3 2026.

  • Apella Capital held 5,575 shares of Lam Research worth $1.84M as of Q3 2026.
  • Apella Capital bought 1,632 Lam Research shares in Q3 2026, an estimated $510K.
  • Lam Research made up 0.02% of Apella Capital's portfolio in Q3 2026, its #295 holding.
  • Apella Capital first reported a position in Lam Research in Q4 2023 and has held it in 12 quarters since.
  • 130 funds tracked by Wall St. Rank held Lam Research as of Q3 2026.

Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.